Contact this trialFirst, we need to learn more about you.
SAR422459 Follow-Up Study for Stargardt Disease
Recruiting1 awardPhase 1 & 2
Portland, Oregon
This trial will evaluate the long-term safety and tolerability of SAR422459 in patients with Stargardt's Macular Degeneration. Secondary objectives include assessing safety and biological activity.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service